Roche paves way for a new era of HCC treatment

Food and Healthcare Press Releases Monday October 19, 2020 16:45
Bangkok--19 Oct--Spark Communications

Roche, the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics, led by Farid Bidgoli (3rd from right), General Manager, Roche Thailand, Myanmar, Cambodia and Laos, along with Saranond Assavavipapan (Left), Integrated Disease Value Lead, Kultida Leenabanchong (2nd from left), Communications Lead, Deepti Saraf (3rd from left), Integrated Disease Value Lead, Morris Chiko (right), Finance and Operations Value Lead and Sansanee Lerdlitruangsin, MD. (2nd from right), Integrated Medical Value Lead, hosted the 'HCC Enters a New Era of Treatment’ seminar. The event brought attention to liver cancer, as the number one cancer killer in Thai men, with exchange of knowledge in new treatment approaches, Thailand specific hepatocellular carcinoma (HCC) research, as well as early experience case discussion in unresectable HCC. The event was joined by close to 100 medical professionals and industry experts at Centara Grand at CentralWorld, recently.


Latest Press Release

BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable...

Official Best of SABCS(R) News - 2020 SABCS(R) Highlights Coverage

Register now to the Official Best of SABCS(R) News 2020 program to get a daily update on the most relevant advances in breast cancer. Encore Medical Education (www.encoremeded.com) will publish a new edition of the Official Best of SABCS(R) News from...

Population Council และ Duchesnay บรรลุข้อตกลงอนุญาตให้ใช้สิทธิในผลิตภัณฑ์คุมกำเนิด ANNOVERA(R)

องค์กรไม่แสวงหาผลกำไร Population Council และบริษัท Duchesnay บรรลุข้อตกลงอนุญาตให้ใช้สิทธิในผลิตภัณฑ์คุมกำเนิด ANNOVERA(R) (segesterone acetate and ethinyl estradiol vaginal system)...

Population Council and Duchesnay Announce New International License Agreement for ANNOVERA(R)

Today the Population Council and Duchesnay announce an exclusive license agreement to make ANNOVERA(R) (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive fully under a woman's control to protect against...

PEOPLE LIVING WITH HIV AND INDIVIDUALS AT-RISK EXPERIENCED DISRUPTION TO HIV CARE IN THAILAND: SURVEY

Results are part of the first Asia Pacific-wide survey that assesses the impact of COVID-19 pandemic on access and delivery of HIV care in the region The survey provides insights on the adoption of telemedicine as the future of HIV care The COVID-19...

Related Topics